-
The authors set out to determine whether daily bathing of patients with 2% chlorhexidine gluconate (CHG)-impregnated cloths could reduce central line-associated bloodstream infection (CLABSI) rate by at least 30% in a surgical ICU where CLABSI rates were above National Healthcare Safety Network averages.
-
In this issue: Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
The overwhelming majority of women who go through pregnancy never require admission to the intensive care unit.
-
More health care workers responded to this season's push for influenza vaccination by rolling up their sleeves and getting the vaccine.
-
When it comes to MRSA infection control in the chaotic emergency department (ED), enhanced attention to standard precautions and hand hygiene is a more cost-effective approach than active screening cultures, researchers report.
-
The national epidemic of Clostridium difficile is moving into the pediatric population, causing infections in children that prolong hospitalizations, increase morbidity and spell a striking increase in the risk of death.
-
Group B streptococcal (GBS) disease is the leading cause of early-onset neonatal sepsis (within the first week of life) in the United States. Since the initial recommendations for perinatal prophylaxis in the 1990s, the incidence of GBS has declined by 80%.
-
A recent federal report that included the highly publicized finding that some 15,000 Medicare patients die every month due to adverse events and hospital-acquired conditions (HAC) may ratchet up pressure on hospitals to prevent infections, which represented some 15% of the HACs.
-
-
The occurrence of skin rash in patients receiving cetuximab is common, and for patients with colon cancer, this has been associated with better clinical outcomes.